Data / Form D filings / Adze Biotechnology Inc
Adze Biotechnology Inc: Form D filings
Adze Biotechnology Inc, a biotechnology company in Coral Gables, FL, filed 10 Form D notices with the SEC between 2019 and 2025. The latest, on November 17, 2025, reports $6.2 million sold of a $15 million offering to 21 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2332 GALIANO STREET, 2ND FL, Coral Gables, FL, 33134
- Phone
- (917) 743-9401
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 1787508
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 17, 2025 | Amendment | $15,000,000 | $6,150,005 | $8,849,995 | 21 | Mar 10, 2023 | sec.gov |
| Feb 19, 2025 | Amendment | $15,000,000 | $6,149,998 | $8,850,002 | 21 | Mar 10, 2023 | sec.gov |
| Feb 22, 2024 | Amendment | $15,000,000 | $6,149,998 | $8,850,002 | 21 | Mar 10, 2023 | sec.gov |
| Mar 14, 2023 | New notice | $15,000,000 | $6,149,998 | $8,850,002 | 21 | Mar 10, 2023 | sec.gov |
| May 19, 2022 | Amendment | $3,687,500 | $3,687,500 | 19 | Dec 12, 2019 | sec.gov | |
| Nov 19, 2021 | Amendment | $4,057,500 | $2,557,500 | $1,500,000 | 9 | Dec 12, 2019 | sec.gov |
| Mar 31, 2021 | Amendment | $3,500,000 | $2,000,000 | $1,500,000 | 5 | Dec 12, 2019 | sec.gov |
| Dec 14, 2020 | Amendment | $3,500,000 | $2,000,000 | $1,500,000 | 5 | Dec 12, 2019 | sec.gov |
| Dec 19, 2019 | Amendment | $3,500,000 | $1,000,000 | $2,500,000 | 4 | Dec 19, 2019 | sec.gov |
| Sep 9, 2019 | New notice | $3,000,000 | $0 | $3,000,000 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Brendan Patrick Kenny | Director | |
| Sidney Hopps | Executive Officer, Director | |
| Gabriel Patrick Raviv | Director | |
| G. Patrick Sage, II | Director |
Other biotechnology companies in Florida that filed recently
- AdhereBio LLC offering · Oct 26, 2026
- Ascoltare Holdings LLC $1.7 million · Oct 23, 2026
- Immorta Bio, Inc. $612,503 · Oct 16, 2026
- CURADEL SURGICAL INNOVATIONS, INC. $49.8 million · Oct 13, 2026
- BioStem Technologies, Inc. $3 million · Oct 9, 2026
- HCW Biologics Inc. $1.5 million · Oct 8, 2026
Every Form D from the week of Nov 17, 2025 · All recent filings in Florida · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Adze Biotechnology Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.